Adam Bluestein

2 weeks ago | fastcompany.com | Adam Bluestein

If you’re at all unsettled by the amount of power that Elon Musk wields on Earth, don’t look up. There are now essentially three big players controlling what goes into space and who gets access to increasingly valuable space-based communications and surveillance services: Russia, China, and Elon Musk.

3 weeks ago | fastcompany.com | Adam Bluestein

A decade may have passed in real time since stepbrothers Phineas Flynn and Ferb Fletcher had their last summertime adventure on TV, but it’s just one unremarkable school year later for the characters in the beloved animated TV series Phineas and Ferb.

3 weeks ago | fastcompany.com | Adam Bluestein

Are you ready for another 140 days of summer vacation? Disney announced today that the long-awaited reboot of its animated hit Phineas and Ferb will be back on June 5 for the start of a 40-episode run across Disney’s linear and streaming platforms. The action picks up the summer after the show’s original run left off, with the kids a year older but not visibly changed—except for an extra orange stripe on Phineas’s trademark T-shirt.

1 month ago | fastcompany.com | Adam Bluestein

The heated race to develop and deploy new large language models and AI products has seen innovation surge—and revenue soar—at companies supporting AI infrastructure. This year’s Most Innovative Companies in computing include TSMC; the Taiwan-based fabricator’s N3P chip offers the smallest, most densely packed transistor size yet, while the company Chip-on-Wafer-on-Substrate (CoWoS) packaging technology is integral to AI accelerator chips, including Nvidia’s Blackwell GPU.

1 month ago | fastcompany.com | Adam Bluestein

This year’s list of biotech companies reflects the evolving impact of AI, a growing interest in cutting-edge research tools for single-cell analysis and spatial proteomics, and clinical advances for novel drug candidates that promise more convenient and effective treatment for conditions impacting millions of Americans. AlzPath’s highly sensitive blood test can detect signs of Alzheimer’s disease before symptoms develop—and in time to potentially benefit from new treatments.